Furthermore, results showed the frequency of CD69-expressing CD3+CD4+ TIGIT+ T lymphocytes was significantly elevated compared to CD3+CD4+ TIGIT− T lymphocytes in SLE patients (P = 0.023) (Fig. 2c). This evidence concerns the gene CD69 and systemic lupus erythematosus.